4//SEC Filing
NODELMAN OLEG 4
Accession 0000935836-25-000266
CIK 0001937653other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 6:34 PM ET
Size
10.5 KB
Accession
0000935836-25-000266
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
EcoR1 Capital, LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2025-04-04$11.17/sh+196,438$2,193,800→ 17,699,774 total(indirect: See Note) - Purchase
Common Stock
2025-04-03$11.84/sh+120,770$1,430,170→ 17,503,336 total(indirect: See Note)
NODELMAN OLEG
Director10% Owner
Transactions
- Purchase
Common Stock
2025-04-03$11.84/sh+120,770$1,430,170→ 17,503,336 total(indirect: See Note) - Purchase
Common Stock
2025-04-04$11.17/sh+196,438$2,193,800→ 17,699,774 total(indirect: See Note)
Footnotes (7)
- [F1]The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein.
- [F2]Qualified Fund purchased 113,233 of the shares purchased in this transaction.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.8101 to $11.9123 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each seperate price within the ranges set forth in this footnote and footnote 6.
- [F4]After this transaction, Qualified Fund held 16,407,320 shares of the Issuer's Common Stock.
- [F5]Qualified Fund purchased 184,181 of the shares purchased in this transaction.
- [F6]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.9804 to $11.2921, inclusive.
- [F7]After this transaction, Qualified Fund held 16,591,501 shares of the Issuer's Common Stock.
Documents
Issuer
Zymeworks Inc.
CIK 0001937653
Entity typeother
Related Parties
1- filerCIK 0001454385
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 6:34 PM ET
- Size
- 10.5 KB